Shady Saad

Shady Saad

Auto-generated profile, based on publicly available information

Shady Saad

Institute of Biochemistry, Department of Biology, ETH Zurich, Zürich, Switzerland

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2017 in Nature Cell Biology
Verified
Journal Article
Closed access
SSShady Saad
Shady Saad
GCGea Cereghetti
Gea Cereghetti
YFYuehan Feng
Yuehan Feng
PPPaola Picotti
Paola Picotti
MPMatthias Peter
Matthias Peter
RDReinhard Dechant
Reinhard Dechant

1 August 2014 in Molecular Cell
Verified
Journal Article
Closed access
RDReinhard Dechant
Reinhard Dechant
SSShady Saad
Shady Saad
ALFREDO J. ​​IBAÑEZALFREDO J. ​​IBAÑEZ
ALFREDO J. ​​IBAÑEZ
MPMatthias Peter
Matthias Peter

6 October 2021 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
GCGea Cereghetti
Gea Cereghetti
CWCaroline Wilson-Zbinden
Caroline Wilson-Zbinden
VKVera M. Kissling
Vera M. Kissling
MDMaren Diether
Maren Diether
AAAlexandra Arm
Alexandra Arm
MPMatthias Peter
Matthias Peter

3 July 2018 in Cell Cycle
Verified
Journal Article
Closed access
GCGea Cereghetti
Gea Cereghetti
SSShady Saad
Shady Saad
RDReinhard Dechant
Reinhard Dechant
MPMatthias Peter
Matthias Peter
Protein aggregates, and in particular amyloids, are generally considered to be inherently irreversible aberrant clumps, and are often associated with pathologies, such as Alzheimer’s disease, Parkinson’s disease, or systemic amyloidosis. However, recent evidence demonstrates that some aggregates are not only fully reversible, but also perform essential physiological functions. Despite these new findings, very little is known about how these functional protein aggregates are regulated in a physiological context. Here, we take the yeast pyruvate kinase Cdc19 as an example of a protein forming functional, reversible, solid, amyloid-like aggregates in response to stress conditions. Cdc19 aggregation is regulated via an aggregation-prone low complexity region (LCR). In favorable growth conditions, this LCR is prevented from aggregating by phosphorylation or oligomerization, while upon glucose starvation it becomes exposed and allows aggregation. We suggest that LCR phosphorylation, oligomerization or partner-binding may be general and widespread mechanisms regulating LCR-mediated reversible protein aggregation. Moreover, we show that, as predicted by computational tools, Cdc19 forms amyloid-like aggregates in vitro. Interestingly, we also observe striking similarities between Cdc19 and its mammalian counterpart, PKM2. Indeed, also PKM2 harbors a LCR and contains several peptides with high amyloidogenic propensity, which coincide with known phosphorylation sites. Thus, we speculate that the formation of reversible, amyloid-like aggregates may be a general physiological mechanism for cells to adapt to stress conditions, and that the underlying regulatory mechanisms may be conserved from yeast to humans.

1 July 2018 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
EGErica Grignaschi
Erica Grignaschi
GCGea Cereghetti
Gea Cereghetti
FGFulvio Grigolato
Fulvio Grigolato
MKMarie R.G. Kopp
Marie R.G. Kopp
SCStefano Caimi
Stefano Caimi
PAPaolo Arosio
Paolo Arosio
Cells form stress granules (SGs) upon stress stimuli to protect sensitive proteins and RNA from degradation. In the yeast Saccharomyces cerevisiae, specific stresses such as nutrient starvation and heat shock were recently shown to trigger recruitment of the yeast pyruvate kinase Cdc19 into SGs. This RNA-binding protein was shown to form amyloid-like aggregates that are physiologically reversible and essential for cell cycle restart after stress. Cellular Cdc19 exists in an equilibrium between a homo-tetramer and monomer state. Here, we show that Cdc19 aggregation in vitro is governed by protein quaternary structure, and we investigate the physical-chemical basis of Cdc19’s assembly properties. Equilibrium shift towards the monomer state exposes a hydrophobic low complexity region (LCR), which is prone to induce intermolecular interactions with surrounding proteins. We further demonstrate that hydrophobic/hydrophilic interfaces can trigger Cdc19 aggregation in vitro. Moreover, we performed in vitro biophysical analyses to compare Cdc19 aggregates with fibrils produced by two known dysfunctional amyloidogenic peptides. We show that the Cdc19 aggregates share several structural features with pathological amyloids formed by human insulin and the Alzheimer disease-associated Abeta42 (Aβ42) peptide, particularly secondary β-sheet structure, thermodynamic stability, and staining by the Thioflavin T dye. However, Cdc19 aggregates could not seed aggregation. These results indicate that Cdc19 adopts an amyloid-like structure in vitro that is regulated by the exposure of a hydrophobic LCR in its monomeric form. Together, our results highlight striking structural similarities between functional and dysfunctional amyloids and reveal the crucial role of hydrophobic/hydrophilic interfaces in regulating Cdc19 aggregation.

1 September 2013 in Physiology
Verified
Journal Article
Closed access
PDF file
SSShady Saad
Shady Saad
MPMatthias Peter
Matthias Peter
RDReinhard Dechant
Reinhard Dechant
Although nutrient availability is a major driver of cell growth, and continuous adaptation to nutrient supply is critical for the development and survival of all organisms, the molecular mechanisms of nutrient sensing are only beginning to emerge. Here, we highlight recent advances in the field of nutrient sensing and discuss arising principles governing how metabolism might regulate growth-promoting pathways. In addition, we discuss signaling functions of metabolic enzymes not directly related to their metabolic activity.